A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...
22h
Zacks.com on MSNAhead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsBeyond analysts' top -and-bottom-line estimates for Gilead (GILD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...
Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.
RBC Capital analyst Brian Abrahams maintained a Hold rating on Neurocrine (NBIX – Research Report) yesterday and set a price target of $148.00.
Salesforce (NYSE:CRM) shares declined 3.7% as the market reacted skeptically to the announcement that Robin Washington will ...
The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.
Ravi Singisetti; Chief Executive Officer, Director; Cognizant Technology Solutions Corp Jatin Dalal; Chief Financial Officer; Cognizant Technology Solutions Corp Thank you, operator, and good ...
Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. […] ...
Hayward, California-based Arcus Biosciences, Inc. (NYSE:RCUS), a company in the pharmaceutical preparations industry with a market capitalization of $1.2 billion, announced today a change to its Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results